These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 24448237)

  • 1. Genetic and phenotypic diversity in breast tumor metastases.
    Almendro V; Kim HJ; Cheng YK; Gönen M; Itzkovitz S; Argani P; van Oudenaarden A; Sukumar S; Michor F; Polyak K
    Cancer Res; 2014 Mar; 74(5):1338-48. PubMed ID: 24448237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions.
    Rivenbark AG; Livasy CA; Boyd CE; Keppler D; Coleman WB
    Exp Mol Pathol; 2007 Oct; 83(2):188-97. PubMed ID: 17540367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genomic heritage of lymph node metastases: implications for clinical management of patients with breast cancer.
    Becker TE; Ellsworth RE; Deyarmin B; Patney HL; Jordan RM; Hooke JA; Shriver CD; Ellsworth DL
    Ann Surg Oncol; 2008 Apr; 15(4):1056-63. PubMed ID: 18246400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases.
    Torres L; Ribeiro FR; Pandis N; Andersen JA; Heim S; Teixeira MR
    Breast Cancer Res Treat; 2007 Apr; 102(2):143-55. PubMed ID: 16906480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node metastases develop through a wider evolutionary bottleneck than distant metastases.
    Reiter JG; Hung WT; Lee IH; Nagpal S; Giunta P; Degner S; Liu G; Wassenaar ECE; Jeck WR; Taylor MS; Farahani AA; Marble HD; Knott S; Kranenburg O; Lennerz JK; Naxerova K
    Nat Genet; 2020 Jul; 52(7):692-700. PubMed ID: 32451459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization.
    Nishizaki T; DeVries S; Chew K; Goodson WH; Ljung BM; Thor A; Waldman FM
    Genes Chromosomes Cancer; 1997 Aug; 19(4):267-72. PubMed ID: 9258662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer primary tumor ER expression pattern predicts its expression concordance in matched synchronous lymph node metastases.
    Zhao J; Hu C; Wang C; Yu W; Guo Y; Shi M; Shui Y; Wei Q
    BMC Cancer; 2018 Dec; 18(1):1290. PubMed ID: 30587150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internodal HER2 heterogeneity of axillary lymph node metastases in breast cancer patients.
    Baroš IV; Tanasković N; Pellas U; Eri Ž; Tadić Latinović L; Tot T
    Bosn J Basic Med Sci; 2019 Aug; 19(3):242-248. PubMed ID: 30957723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
    Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
    Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal genotype in breast cancer progression: comparison of primary and secondary manifestations.
    Friedrich K; Weber T; Scheithauer J; Meyer W; Haroske G; Kunze KD; Baretton G
    Cell Oncol; 2008; 30(1):39-50. PubMed ID: 18219109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordance Rate in Estrogen Receptor, Progesterone Receptor, HER2 Status, and Ki67 Index Between Primary Unifocal and Multiple Homogenous Breast Carcinomas and Synchronous Axillary Lymph Node Metastases Have an Impact on Therapeutic Decision.
    Georgescu R; Boros M; Moncea D; Bauer O; Coros MF; Oprea A; Moldovan C; Podoleanu C; Stolnicu S
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):533-538. PubMed ID: 28099174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases.
    Bonsing BA; Corver WE; Fleuren GJ; Cleton-Jansen AM; Devilee P; Cornelisse CJ
    Genes Chromosomes Cancer; 2000 Jun; 28(2):173-83. PubMed ID: 10825002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER2 gene status in primary breast cancers and matched distant metastases.
    Tapia C; Savic S; Wagner U; Schönegg R; Novotny H; Grilli B; Herzog M; Barascud AD; Zlobec I; Cathomas G; Terracciano L; Feichter G; Bubendorf L
    Breast Cancer Res; 2007; 9(3):R31. PubMed ID: 17511881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
    Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
    Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
    [No Abstract]   [Full Text] [Related]  

  • 15. Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?
    Falck AK; Fernö M; Bendahl PO; Rydén L
    World J Surg; 2010 Jul; 34(7):1434-41. PubMed ID: 20213203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of HER2 gene status between primary breast cancer and synchronous axillary lymph node metastasis].
    Liu YY; Wu SF; Liang ZY; Zeng X
    Zhonghua Bing Li Xue Za Zhi; 2016 Jun; 45(6):393-6. PubMed ID: 27256047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review.
    Carlsson J; Nordgren H; Sjöström J; Wester K; Villman K; Bengtsson NO; Ostenstad B; Lundqvist H; Blomqvist C
    Br J Cancer; 2004 Jun; 90(12):2344-8. PubMed ID: 15150568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells.
    Workman HC; Miller JK; Ingalla EQ; Kaur RP; Yamamoto DI; Beckett LA; Young LJ; Cardiff RD; Borowsky AD; Carraway KL; Sweeney C; Carraway KL
    Breast Cancer Res; 2009; 11(5):R70. PubMed ID: 19761616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.
    Bonsing BA; Devilee P; Cleton-Jansen AM; Kuipers-Dijkshoorn N; Fleuren GJ; Cornelisse CJ
    Cancer Res; 1993 Aug; 53(16):3804-11. PubMed ID: 8101767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases--aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial.
    Falck AK; Fernö M; Bendahl PO; Rydén L
    BMC Cancer; 2013 Nov; 13():558. PubMed ID: 24274821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.